all report title image
  • Published On : Aug 2022
  • Code : CMI5194
  • Industry : Medical Devices
  • Pages : 180
  • Formats :

Percutaneous transluminal coronary angioplasty (PTCA) also called percutaneous coronary intervention (PCI) is a minimally invasive procedure to open blocked or stenosed coronary arteries allowing unobstructed blood flow to the myocardium. The blockage occurs because of lipid-rich plaque within the arteries, diminishing blood flow to the myocardium. The accumulation of lipid-rich plaque in the arteries is known as atherosclerosis, and when atherosclerosis affects the coronary arteries, the disorder is known as coronary artery disease.

A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end. A PTCA balloon catheter has a single or double lumen shaft. The catheter features a balloon of appropriate compliance for clinical application, constructed from a polymer.

The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at US$ 2.2 Billion in 2022 and is expected to exhibit a CAGR of 8 % over the forecast period (2022-2030)

Figure 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Value (US$ Mn), By Region, 2022

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter  | Coherent Market Insights

Increasing cardiovascular disease epidemiology worldwide is expected to boost the percutaneous transluminal coronary angioplasty (PTCA) market growth over the forecast period.

For instance, according to the data published in the Centers for Disease Control and Prevention in 2020, in the year 2020, about 20.1 million adults age 20 and older had cardiovascular diseases (about 7.2%), and about 2 in 10 deaths from cardiovascular diseases happened in adults less than 65 years old in U.S.

CMI table icon

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 2.2 Bn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 8% 2030 Value Projection: US$ 4.1 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter
  • By Balloon Material: Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)
  • By End User: Hospitals, Ambulatory Surgical Centers
Companies covered:

Cook Group, Medtronic Plc., Becton Dickinson and Company, Abbott, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.

Growth Drivers:
  • Increasing product launches
  • Increasing cardiac disease population
Restraints & Challenges:
  • Increasing product recalls

Figure 2. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Share (%), By Product Type, 2022

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter  | Coherent Market Insights

Increasing product launches and approvals are expected to drive the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period.

For instance, in July 2021, MedAlliance, a medical technology company headquartered in Switzerland, had launched ORIGIN NC, two high-performance balloons for vessel preparation. ORIGIN SC is a semi-compliant (SC) PTCA with a very low crossing profile. Its sizes include 1.00 mm, 1.25 mm, 1.50 mm, and 1.75 mm balloon diameter to treat very small vessels and complex cases.

ORIGIN NC is a non-compliant (NC) PTCA balloon, combining high-pressure tolerance and controlled compliance with an optimal crossing profile for challenging cases.

Moreover, in August 2018, S3V Vascular Technologies Private Limited, a medical devices manufacturing company, launched Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters.

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 583,038,110 cases of coronavirus disease (COVID-19) were reported till August 9, 2022, across the globe.

Cardiac surgery patients have an increased risk of complications from COVID-19 and require vital finite resources such as intensive care beds, and same needed by the covid-19 patient, thus admission of cardiac patient was reduced during the peak of covid-19 spread. Moreover, only emergencies such as acute aortic dissections were treated.

Moreover, according to an article published by CTV new in September 2021, Hamilton General Hospital had to cancel all cardiac surgeries for an entire day as it scramble to free up resources to care for COVID-19 patients in its intensive care unit.         

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Restraint

Increasing product recalls are expected to hinder the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period. For instance, in February 2020, Abbott, a medical device and healthcare company, had voluntarily recalled specific lots of two types of its coronary angioplasty catheters – NC Trek RX Coronary Dilatation Catheter and NC Traveler Coronary Dilatation Catheter, as the balloons from the impacted lots may not deflect as intended, and the U.S Food and Drug Administration has classified this as Class I recall.

Key Players

Major players operating in the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market include Cook Group, Medtronic Plc., Becton, Dickinson and Company, Abbott, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.

Percutaneous transluminal coronary angioplasty is commonly called PTCA, or just angioplasty. A catheter is inserted into an artery usually into the groin and sometimes in the arm or wrist. The catheter is advanced to the heart, and a series of x-ray pictures are taken to clearly visualize the heart arteries that are narrowed. Then, a balloon-tipped catheter is advanced to the heart, and into the narrow coronary artery. Inside the artery, the balloon is inflated and deflated several times, compressing the plaque against the artery wall and widening the artery for the blood flow to improve. X-rays pictures are repeated, and if the artery has been successfully re-opened, the catheters are removed.

Market Dynamics

The increasing coronary artery disease population, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period.

For instance, in May 2022, Medtronic, a medical device company, announced that it received approval from the U.S food and drug administration (FDA) for IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter, a drug coated balloon (DCB), indicated for the interventional treatment of peripheral artery disease (PAD) in the superficial and popliteal arteries.

Moreover, according to the data published in American Heart Association in July 2021, lower extremity peripheral artery disease (PAD) affects more than 230 million adults worldwide.

Key features of the study:

  • This report provides an in-depth analysis of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Cook Group, Medtronic Plc., Becton, Dickinson and Company, Abbott, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market

Detailed Segmentation:

  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type:
    • Normal Balloon Catheter
    • Drug Eluting Balloon Catheter
    • Cutting Balloon Catheter
    • Scoring Balloon Catheter
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Balloon Material:
    • Polyolefin copolymer (POC)
    • Polyethylene (PE)
    • Polyethylene terephthalate (PET)
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Cook Group.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Medtronic Plc
    • Becton Dickinson and Company
    • Abbott
    • Koninklijke Philips N.V.
    • ENDOCOR GmbH
    • Cardinal Health
    • NIPRO
    • Terumo Corporation
    • Boston Scientific Corporation
    • Surmodics, Inc.
    • Teleflex Incorporated
    • BIOTRONIK SE & Co. KG
    • Biomerics
    • Shockwave Medical Inc.
    • Microport Scientific Corporation
    • Nordson Corporation
    • S3V Vascular Technologies Pvt. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at US $ 2.2 Billion in 2022 and is expected to exhibit a CAGR of 8 % between 2022 and 2030.
Increasing product launches and increasing cardiac disease population are the major factors driving the market growth.
Normal balloon catheter is expected to hold a major market share over the forecast period owing to increasing product launches.
North America holds the largest market share in the market.
Major players operating in the market include Cook Group, Medtronic Plc., Becton, Dickinson and Company, Abbott, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo